NRG Therapeutics unpacks the molecular switch behind its ALS drug candidate, adding fresh mechanistic evidence to a trial already underway.
Link as first comment.
#longevity #geroscience #nrgtherapeutics #als #drugcandidate
@alsassociation
Link as first comment.
#longevity #geroscience #nrgtherapeutics #als #drugcandidate
@alsassociation
September 9, 2026 at 2:20 PM
NRG Therapeutics unpacks the molecular switch behind its ALS drug candidate, adding fresh mechanistic evidence to a trial already underway.
Link as first comment.
#longevity #geroscience #nrgtherapeutics #als #drugcandidate
@alsassociation
Link as first comment.
#longevity #geroscience #nrgtherapeutics #als #drugcandidate
@alsassociation
#MissionTherapeutics #Dimerix #kidneydisease #renal #Parkinsonsdisease #outlicensing #acutekidneyinjury #biotech #MTX652 #drugcandidate #deubiquitylatingenzymes #DUBs #mitophagy #acutekidneydisease #neurodegenerativediseases #Alzheimers #Huntingtons #amyotrophiclateralsclerosis #ALS
zurl.co/oEToB
zurl.co/oEToB
UK's Mission divests kidney drug to Dimerix for $292m
Mission Therapeutics has struck a deal to out-license a drug for acute kidney injury to Australia's Dimerix, sharpening its focus on CNS diseases.
pharmaphorum.com
July 21, 2026 at 12:31 PM
🦠 New #DrugCandidate targets for #tuberculosis? Dos Santos Silva and Dias review #structure, physiological role and medical potential of the #Mycobacterium superfamily of cell wall hydrolases NlpC_60.
➡️ doi.org/10.1002/1873-3468.70021
#bacteria #microbiology #drugtarget
➡️ doi.org/10.1002/1873-3468.70021
#bacteria #microbiology #drugtarget
April 24, 2025 at 11:03 AM
🦠 New #DrugCandidate targets for #tuberculosis? Dos Santos Silva and Dias review #structure, physiological role and medical potential of the #Mycobacterium superfamily of cell wall hydrolases NlpC_60.
➡️ doi.org/10.1002/1873-3468.70021
#bacteria #microbiology #drugtarget
➡️ doi.org/10.1002/1873-3468.70021
#bacteria #microbiology #drugtarget